United States Drugs for Malaria Market by Manufacturers, States, Type and Application, Forecast to 2023

May 2018 | 100 pages | ID: U46F7D59916EN
GlobalInfoResearch

Abstracts

'Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.

Scope of the Report:

This report focuses on the Drugs for Malaria in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers'

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Market Segment by Type, covers

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

Market Segment by Applications, can be divided into

• Prevention
• Treatment
• Other

There are 17 Chapters to deeply display the United States Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Drugs for Malaria, for each state, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10 and 11, to analyze the key States by Type and Application, covering California, New York, Texas, Illinois and Florida, with sales, revenue and market share by types and applications;

Chapter 12, Drugs for Malaria market forecast, by States, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 15, to describe sales channel, distributors, traders, dealers, etc.

Chapter 16 and 17, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source.

Contents

1 MARKET OVERVIEW

1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
  1.2.1 Aryl Aminoalcohol Compounds
  1.2.2 Antifolate Compounds
  1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
  1.3.1 Prevention
  1.3.2 Treatment
  1.3.3 Other
1.4 Market Analysis by States
  1.4.1 California Status and Prospect (2013-2023)
  1.4.2 Texas Status and Prospect (2013-2023)
  1.4.3 New York Status and Prospect (2013-2023)
  1.4.4 Florida Status and Prospect (2013-2023)
  1.4.5 Illinois Status and Prospect (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Cipla
  2.1.1 Business Overview
  2.1.2 Drugs for Malaria Type and Applications
    2.1.2.1 Type
    2.1.2.2 Type
  2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Guilin Pharmaceutical
  2.2.1 Business Overview
  2.2.2 Drugs for Malaria Type and Applications
    2.2.2.1 Type
    2.2.2.2 Type
  2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 IPCA Laboratories
  2.3.1 Business Overview
  2.3.2 Drugs for Malaria Type and Applications
    2.3.2.1 Type
    2.3.2.2 Type
  2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 GlaxoSmithKline
  2.4.1 Business Overview
  2.4.2 Drugs for Malaria Type and Applications
    2.4.2.1 Type
    2.4.2.2 Type
  2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Mylan Labs
  2.5.1 Business Overview
  2.5.2 Drugs for Malaria Type and Applications
    2.5.2.1 Type
    2.5.2.2 Type
  2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Roche
  2.6.1 Business Overview
  2.6.2 Drugs for Malaria Type and Applications
    2.6.2.1 Type
    2.6.2.2 Type
  2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Novartis
  2.7.1 Business Overview
  2.7.2 Drugs for Malaria Type and Applications
    2.7.2.1 Type
    2.7.2.2 Type
  2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Sanofi Aventis
  2.8.1 Business Overview
  2.8.2 Drugs for Malaria Type and Applications
    2.8.2.1 Type
    2.8.2.2 Type
  2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Ajanta Pharma
  2.9.1 Business Overview
  2.9.2 Drugs for Malaria Type and Applications
    2.9.2.1 Type
    2.9.2.2 Type
  2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 UNITED STATES DRUGS FOR MALARIA MARKET COMPETITION, BY MANUFACTURER

3.1 United States Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
  3.1.1 United States Drugs for Malaria Sales by Manufacturer (2016-2017)
  3.1.2 United States Drugs for Malaria Sales Market Share by Manufacturer (2016-2017)
3.2 United States Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
  3.2.1 United States Drugs for Malaria Revenue by Manufacturer (2016-2017)
  3.2.2 United States Drugs for Malaria Revenue Market Share by Manufacturer (2016-2017)
3.3 United States Drugs for Malaria Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share (2016-2017)
  3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend

4 UNITED STATES DRUGS FOR MALARIA MARKET ANALYSIS BY STATES

4.1 United States Drugs for Malaria Sales Market Share by States (2013-2018)
4.2 United States Drugs for Malaria Sales and Market Share by States (2013-2018)
  4.2.1 United States Drugs for Malaria Sales by States (2013-2018)
  4.2.2 United States Drugs for Malaria Sales Market Share by States (2013-2018)
4.3 United States Drugs for Malaria Revenue (Value) and Market Share by States (2013-2018)
  4.3.1 United States Drugs for Malaria Revenue by States (2013-2018)
  4.3.2 United States Drugs for Malaria Revenue Market Share by States (2013-2018)

5 UNITED STATES MARKET SEGMENTATION DRUGS FOR MALARIA BY TYPE

5.1 United States Drugs for Malaria Sales, Revenue and Market Share by Type (2013-2018)
  5.1.1 United States Drugs for Malaria Sales and Market Share by Type (2013-2018)
  5.1.2 United States Drugs for Malaria Revenue and Market Share by Type (2013-2018)
5.2 Type 1 Sales Growth Rate and Price
5.2 Aryl Aminoalcohol Compounds Sales Growth and Price
  5.2.1 United States Aryl Aminoalcohol Compounds Sales Growth (2012-2017)
  5.2.2 United States Aryl Aminoalcohol Compounds Price (2012-2017)
5.3 Antifolate Compounds Sales Growth and Price
  5.3.1 United States Antifolate Compounds Sales Growth (2012-2017)
  5.3.2 United States Antifolate Compounds Price (2012-2017)
5.4 Artemisinin Compounds Sales Growth and Price
  5.4.1 United States Artemisinin Compounds Sales Growth (2012-2017)

6 UNITED STATES MARKET SEGMENTATION DRUGS FOR MALARIA BY APPLICATION

6.1 United States Drugs for Malaria Sales Market Share by Application (2013-2018)
6.2 Prevention Sales Growth (2012-2017)
6.3 Treatment Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)

7 CALIFORNIA DRUGS FOR MALARIA SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

7.1 California Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
7.2 California Drugs for Malaria Sales and Market Share by Type (2013-2018)
  7.2.1 California Drugs for Malaria Sales by Type (2013-2018)
  7.2.2 California Drugs for Malaria Sales Market Share by Type (2013-2018)
7.3 California Drugs for Malaria Sales and Market Share by Application (2013-2018)
  7.3.1 California Drugs for Malaria Sales by Application (2013-2018)
  7.3.2 California Drugs for Malaria Sales Market Share by Application (2013-2018)

8 NEW YORK DRUGS FOR MALARIA SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

8.1 New York Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
8.2 New York Drugs for Malaria Sales and Market Share by Type (2013-2018)
  8.2.1 New York Drugs for Malaria Sales by Type (2013-2018)
  8.2.2 New York Drugs for Malaria Sales Market Share by Type (2013-2018)
8.3 New York Drugs for Malaria Sales and Market Share by Application (2013-2018)
  8.3.1 New York Drugs for Malaria Sales by Application (2013-2018)
  8.3.2 New York Drugs for Malaria Sales Market Share by Application (2013-2018)

9 TEXAS DRUGS FOR MALARIA SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

9.1 Texas Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
9.2 Texas Drugs for Malaria Sales and Market Share by Type (2013-2018)
  9.2.1 Texas Drugs for Malaria Sales by Type (2013-2018)
  9.2.2 Texas Drugs for Malaria Sales Market Share by Type (2013-2018)
9.3 Texas Drugs for Malaria Sales and Market Share by Application (2013-2018)
  9.3.1 Texas Drugs for Malaria Sales by Application (2013-2018)
  9.3.2 Texas Drugs for Malaria Sales Market Share by Application (2013-2018)

10 FLORIDA DRUGS FOR MALARIA SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

10.1 Florida Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
10.2 Florida Drugs for Malaria Sales and Market Share by Type (2013-2018)
  10.2.1 Florida Drugs for Malaria Sales by Type (2013-2018)
  10.2.2 Florida Drugs for Malaria Sales Market Share by Type (2013-2018)
10.3 Florida Drugs for Malaria Sales and Market Share by Application (2013-2018)
  10.3.1 Florida Drugs for Malaria Sales by Application (2013-2018)
  10.3.2 Florida Drugs for Malaria Sales Market Share by Application (2013-2018)

11 ILLINOIS DRUGS FOR MALARIA SALES, REVENUE, BY TYPE, APPLICATION AND MANUFACTURERS

11.1 Illinois Drugs for Malaria Revenue, Sales and Growth Rate (2013-2018)
11.2 Illinois Drugs for Malaria Sales and Market Share by Type (2013-2018)
  11.2.1 Illinois Drugs for Malaria Sales by Type (2013-2018)
  11.2.2 Illinois Drugs for Malaria Sales Market Share by Type (2013-2018)
11.3 Illinois Drugs for Malaria Sales and Market Share by Application (2013-2018)
  11.3.1 Illinois Drugs for Malaria Sales by Application (2013-2018)
  11.3.2 Illinois Drugs for Malaria Sales Market Share by Application (2013-2018)

12 DRUGS FOR MALARIA MARKET FORECAST (2018-2023)

12.1 United States Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
12.2 Drugs for Malaria Market Forecast by States (2018-2023)
  12.2.1 United States Drugs for Malaria Sales Forecast by States (2018-2023)
  12.2.2 United States Drugs for Malaria Market Share Forecast by States (2018-2023)
12.3 Drugs for Malaria Market Forecast by Type (2018-2023)
  12.3.1 United States Drugs for Malaria Sales Forecast by Type (2018-2023)
  12.3.2 United States Drugs for Malaria Market Share Forecast by Type (2018-2023)
12.4 Drugs for Malaria Market Forecast by Application (2018-2023)
  12.4.1 United States Drugs for Malaria Sales Forecast by Application (2018-2023)
  12.4.2 United States Drugs for Malaria Market Share Forecast by Application (2018-2023)

13 DRUGS FOR MALARIA MANUFACTURING COST ANALYSIS

13.1 Drugs for Malaria Key Raw Materials Analysis
  13.1.1 Key Raw Materials
  13.1.2 Price Trend of Key Raw Materials
  13.1.3 Key Suppliers of Raw Materials
  13.1.4 Market Concentration Rate of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
  13.2.1 Raw Materials
  13.2.2 Labor Cost
  13.2.3 Manufacturing Expenses
13.3 Manufacturing Process Analysis of Drugs for Malaria

14 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

14.1 Drugs for Malaria Industrial Chain Analysis
14.2 Upstream Raw Materials Sourcing
14.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2017
14.4 Downstream Buyers

15 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

15.1 Sales Channel
  15.1.1 Direct Marketing
  15.1.2 Indirect Marketing
  15.1.3 Marketing Channel Future Trend
15.2 Distributors, Traders and Dealers

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology
17.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Drugs for Malaria Picture
Table Product Specifications of Drugs for Malaria
Figure United States Sales Market Share of Drugs for Malaria by Types in 2017
Table Types of Drugs for Malaria
Figure Aryl Aminoalcohol Compounds Picture
Figure Antifolate Compounds Picture
Figure Artemisinin Compounds Picture
Figure United States Drugs for Malaria Sales Market Share by Applications in 2017
Table Applications of Drugs for Malaria
Figure Prevention Picture
Figure Treatment Picture
Figure Other Picture
Figure California Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2023)
Figure Texas Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2023)
Figure New York Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2023)
Figure Florida Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2023)
Figure Illinois Drugs for Malaria Revenue (Million USD) and Growth Rate (2013-2023)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Drugs for Malaria Type and Applications
Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Guilin Pharmaceutical Drugs for Malaria Type and Applications
Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table IPCA Laboratories Drugs for Malaria Type and Applications
Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Drugs for Malaria Type and Applications
Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Labs Basic Information, Manufacturing Base and Competitors
Table Mylan Labs Drugs for Malaria Type and Applications
Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Drugs for Malaria Type and Applications
Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drugs for Malaria Type and Applications
Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi Aventis Drugs for Malaria Type and Applications
Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table Ajanta Pharma Drugs for Malaria Type and Applications
Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United States Drugs for Malaria Sales by Manufacturer (2016-2017)
Table United States Drugs for Malaria Sales Market Share by Manufacturer (2016-2017)
Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2017
Table United States Drugs for Malaria Revenue by Manufacturer (2016-2017)
Table United States Drugs for Malaria Revenue Market Share by Manufacturer (2016-2017)
Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2016
Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2017
Table United States Drugs for Malaria Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2016
Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2017
Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2016
Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2017
Figure United States Drugs for Malaria Sales and Growth Rate (2013-2018)
Table United States Drugs for Malaria Sales by States (2013-2018)
Table United States Drugs for Malaria Sales Market Share by States (2013-2018)
Figure United States Drugs for Malaria Sales Market Share by States in 2013
Figure United States Drugs for Malaria Sales Market Share by States in 2017
Table United States Drugs for Malaria Revenue by States (2013-2018)
Figure United States Drugs for Malaria Revenue and Growth Rate (2013-2018)
Table United States Drugs for Malaria Revenue Market Share by States (2013-2018)
Figure United States Drugs for Malaria Revenue Market Share by States in 2013
Figure United States Drugs for Malaria Revenue Market Share by States in 2017
Table United States Drugs for Malaria Sales by Type (2013-2018)
Table United States Drugs for Malaria Sales Share by Type (2013-2018)
Table United States Drugs for Malaria Revenue by Type (2013-2018)
Table United States Drugs for Malaria Revenue Share by Type (2013-2018)
Figure United States Aryl Aminoalcohol Compounds Sales Growth (2012-2017)
Figure United States Aryl Aminoalcohol Compounds Price (2012-2017)
Figure United States Antifolate Compounds Sales Growth (2012-2017)
Figure United States Antifolate Compounds Price (2012-2017)
Figure United States Artemisinin Compounds Sales Growth (2012-2017)
Figure United States Artemisinin Compounds Price (2012-2017)
Table United States Drugs for Malaria Sales by Application (2012-2017)
Table United States Drugs for Malaria Sales Share by Application (2012-2017)
Figure United States Prevention Sales Growth (2012-2017)
Figure United States Treatment Sales Growth (2012-2017)
Figure United States Other Sales Growth (2012-2017)
Figure California Drugs for Malaria Revenue and Growth Rate (2013-2018)
Figure California Drugs for Malaria Sales and Growth Rate (2013-2018)
Table California Drugs for Malaria Sales by Type (2013-2018)
Table California Drugs for Malaria Sales Market Share by Type (2013-2018)
Table California Drugs for Malaria Sales by Application (2013-2018)
Table California Drugs for Malaria Sales Market Share by Application (2013-2018)
Figure New York Drugs for Malaria Revenue and Growth Rate (2013-2018)
Figure New York Drugs for Malaria Sales and Growth Rate (2013-2018)
Table New York Drugs for Malaria Sales by Type (2013-2018)
Table New York Drugs for Malaria Sales Market Share by Type (2013-2018)
Table New York Drugs for Malaria Sales by Application (2013-2018)
Table New York Drugs for Malaria Sales Market Share by Application (2013-2018)
Figure Texas Drugs for Malaria Revenue and Growth Rate (2013-2018)
Figure Texas Drugs for Malaria Sales and Growth Rate (2013-2018)
Table Texas Drugs for Malaria Sales by Type (2013-2018)
Table Texas Drugs for Malaria Sales Market Share by Type (2013-2018)
Table Texas Drugs for Malaria Sales by Application (2013-2018)
Table Texas Drugs for Malaria Sales Market Share by Application (2013-2018)
Figure Florida Drugs for Malaria Revenue and Growth Rate (2013-2018)
Figure Florida Drugs for Malaria Sales and Growth Rate (2013-2018)
Table Florida Drugs for Malaria Sales by Type (2013-2018)
Table Florida Drugs for Malaria Sales Market Share by Type (2013-2018)
Table Florida Drugs for Malaria Sales by Application (2013-2018)
Table Florida Drugs for Malaria Sales Market Share by Application (2013-2018)
Figure Illinois Drugs for Malaria Revenue and Growth Rate (2013-2018)
Figure Illinois Drugs for Malaria Sales and Growth Rate (2013-2018)
Table Illinois Drugs for Malaria Sales by Type (2013-2018)
Table Illinois Drugs for Malaria Sales Market Share by Type (2013-2018)
Table Illinois Drugs for Malaria Sales by Application (2013-2018)
Table Illinois Drugs for Malaria Sales Market Share by Application (2013-2018)
Figure United States Drugs for Malaria Sales, Revenue and Growth Rate (2018-2023)
Table United States Drugs for Malaria Sales Forecast by States (2018-2023)
Table United States Drugs for Malaria Market Share Forecast by States (2018-2023)
Table United States Drugs for Malaria Sales Forecast by Type (2018-2023)
Table United States Drugs for Malaria Market Share Forecast by Type (2018-2023)
Table United States Drugs for Malaria Sales Forecast by Application (2018-2023)
Table United States Drugs for Malaria Market Share Forecast by Application (2018-2023)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2017
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders/ Dealers List